Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Fujizuka

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Oncology|August 20, 2014
Next-generation prostate-specific antigen test: precursor form of prostate-specific antigenKazuto Ito, Yuji Fujizuka, Kiyohide Ishikura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 3, 2016
[A Case of Primary Renal Malignant Lymphoma Initially Managed as Severe Pyelonephritis in a Patient Undergoing Hemodialysis]Yuji Fujizuka, Tomomi Suzuki, Koichi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 2, 2015
Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesKoji Okihara, Atsushi Ochiai, Kazumi Kamoi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[Malignant Central Nervous System Lymphoma after Radical Total Cystectomy : A Diagnostic Challenge]Yuji Fujizuka, Koichi Suzuki, Tatsuhiro Sawada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 2017
Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mLYuji Fujizuka, Kazuto Ito, Ryo Oki, et al.
IJU Case Reports|November 4, 2025
Intermittent Recurrence of Ureterosciatic Hernia After Spontaneous Resolution, Complicated by Emphysematous PyelonephritisAkira Ohtsu, Keisuke Hori, Seiji Arai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 31, 2023
The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamideYoshiyuki Miyazawa, Keisuke Hori, Yusuke Tsuji, et al.
IJU Case Reports|January 6, 2023
Two cases of CRPC with <i>BRCA</i> mutation treated by olaparib after favorable response to cisplatinYoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, et al.
IJU Case Reports|January 3, 2025
Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Guérin immunotherapyTatsuhiro Sawada, Ayaka Igarashi, Seiji Arai, et al.
IJU Case Reports|December 23, 2025
Computed Tomography-Guided Biopsy of a Ureteral Urothelial Carcinoma Mimicking a Submucosal Bladder Tumor at the Ureterovesical JunctionAkira Ohtsu, Yuji Fujizuka, Seiji Arai, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Oncology|August 20, 2014
Next-generation prostate-specific antigen test: precursor form of prostate-specific antigenKazuto Ito, Yuji Fujizuka, Kiyohide Ishikura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 3, 2016
[A Case of Primary Renal Malignant Lymphoma Initially Managed as Severe Pyelonephritis in a Patient Undergoing Hemodialysis]Yuji Fujizuka, Tomomi Suzuki, Koichi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 2, 2015
Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesKoji Okihara, Atsushi Ochiai, Kazumi Kamoi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[Malignant Central Nervous System Lymphoma after Radical Total Cystectomy : A Diagnostic Challenge]Yuji Fujizuka, Koichi Suzuki, Tatsuhiro Sawada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 2017
Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mLYuji Fujizuka, Kazuto Ito, Ryo Oki, et al.
IJU Case Reports|November 4, 2025
Intermittent Recurrence of Ureterosciatic Hernia After Spontaneous Resolution, Complicated by Emphysematous PyelonephritisAkira Ohtsu, Keisuke Hori, Seiji Arai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 31, 2023
The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamideYoshiyuki Miyazawa, Keisuke Hori, Yusuke Tsuji, et al.
IJU Case Reports|January 6, 2023
Two cases of CRPC with <i>BRCA</i> mutation treated by olaparib after favorable response to cisplatinYoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, et al.
IJU Case Reports|January 3, 2025
Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Guérin immunotherapyTatsuhiro Sawada, Ayaka Igarashi, Seiji Arai, et al.
IJU Case Reports|December 23, 2025
Computed Tomography-Guided Biopsy of a Ureteral Urothelial Carcinoma Mimicking a Submucosal Bladder Tumor at the Ureterovesical JunctionAkira Ohtsu, Yuji Fujizuka, Seiji Arai, et al.
Pageof 3